Andrew Kennedy, MD, FACRO

Sarah Cannon Cancer Center at TriStar Health
Nashville, TN, United States

Disclosures:

• Employment: none
• Compensation: ABK Biomedical: Consultant, Research Grants, Research Funding, Research Salary Support,Travel Expenses, Compensation Payment-End Date: present ;Bard: Consultant, Compensation Payment-End Date: present
• Ownership: none
• Leadership: none

Presentation(s):

• 2323 - A Quantitative Comparison of CT- and PET/SPECT-Based Dosimetry Following Yttrium-90 Radioembolization with Radiopaque Glass Microspheres

  Sunday, September 29, 2024
  4:45 PM – 6:00 PM ET

• 2539 - Brain Metastases Treated by Stereotactic Radiotherapy: Real-Time Surveillance of Acute and Delayed Toxicities via Enterprise-Wide Standardized Radiation Oncology OIS Platform

  Monday, September 30, 2024
  10:45 AM – 12:00 PM ET

• 3386 - Utility of Analytics in a Large Community-Based Radiation Oncology Network: Consolidation and Standardization of Clinical, Operational and Quality Metrics

  Tuesday, October 1, 2024
  4:00 PM – 5:00 PM ET